Risk stratification system for chronic disease identification through continuous health parameter monitoring. Leverages AI algorithms and wearable sensor data for predictive health risk evaluation.
Manufactured by
China
Wuhan Jiule Technology Co., Ltd., established in 2012, provides health management services focusing on automated life monitoring, early warning, and risk intervention for individuals with limited mobility. The company has developed wearable health monitoring devices with NMPA Class II medical device certification. Solutions are applied in smart hospital wards, remote rehabilitation, intelligent follow-up, emergency care, and occupational health monitoring for industries including power, construction, and transportation.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Siemens Healthineers
United States · 2 relevant products
Mediwhale Inc.
South Korea · 1 relevant product
ARPI, Inc
South Korea · 1 relevant product
Netown Corporation
Taiwan · 1 relevant product
Cardiex Limited
China · 2 relevant products
Chengdu Stork Healthcare Co.,Ltd.
China · 1 relevant product
Optain Health
Australia · 1 relevant product
APOLO AI SYSTEMS AND DEVELOPMENT S.L.
Spain · 1 relevant product
TALOS Corp.
South Korea · 1 relevant product
See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
11 of 11 closest product alternatives
Siemens Healthineers · United States
Integrated testing platform providing comprehensive evaluation of cardiometabolic health parameters for earlier risk detection. Supports longitudinal monitoring and holistic patient assessment.
Mediwhale Inc. · South Korea
AI system that analyzes retinal images to predict kidney disease risk. Leverages retinal biomarkers to identify patients at elevated risk for progressive kidney disease.
ARPI, Inc · South Korea
Platform that evaluates ECG data to identify critical cardiac conditions including shock, respiratory distress, cardiac arrest, and severe electrolyte imbalances requiring emergency intervention. Delivers analysis results in real-time for emergency transport scenarios.
Netown Corporation · Taiwan
Specialized screening platform utilizing artificial intelligence for health assessment in high-risk and vulnerable populations. Enables early identification of health conditions requiring intervention.
Cardiex Limited · China
Digital vascular biomarker platform for arterial health screening and remote cardiovascular monitoring. Enables point-of-care risk stratification, early disease detection, and progression tracking through non-invasive assessment of arterial stiffness and vascular health status.
Chengdu Stork Healthcare Co.,Ltd. · China
Automated system for real-time cardiovascular metric measurement and assessment, including carotid plaque detection and evaluation. Significantly improves diagnostic efficiency and accuracy in cardiovascular risk stratification.
Cardiex Limited · China
Clinical assessment tool evaluating arterial health and identifying patients at elevated risk for cardiovascular, metabolic, renal, and neurological diseases. Generates objective vascular biomarker data to guide clinical decision-making and patient management.
Siemens Healthineers · United States
Comprehensive testing system providing earlier and more holistic assessment of cardiometabolic health with integrated biomarker analysis for risk identification and management.
Optain Health · Australia
Non-invasive screening system utilizing AI algorithms to detect referable retinal diseases and chronic conditions from fundus images. The system generates comprehensive health risk reports for population screening and disease risk stratification.
APOLO AI SYSTEMS AND DEVELOPMENT S.L. · Spain
Artificial intelligence system designed to identify subtle disease indicators through analysis of medical data. The technology enables early detection and timely clinical intervention for more effective patient treatment outcomes.
TALOS Corp. · South Korea
An artificial intelligence algorithm that evaluates clinical data to predict brain aneurysm risk levels in patients. The system provides quantitative risk stratification to support clinical decision-making for preventive interventions. Applicable to screening programs across healthcare organizations.
© 2026 Suplivia · Home · Browse Products